Product Details

Betamethasone + Neomycin + Clotrimazole 0.025% + 0.5% + 1% Cream delivers a high-quality topical combination therapy formulated to Indian Pharmacopoeia (IP) standards. This fixed-dose triple combination manages corticosteroid-responsive dermatoses complicated by bacterial and fungal infection, combining anti-inflammatory, antibacterial, and antifungal action in a single topical preparation.

The cream combines:

• Betamethasone (as Betamethasone Dipropionate), a corticosteroid that reduces inflammation, redness, and itching by suppressing the local inflammatory response,
• Neomycin Sulphate, an aminoglycoside antibiotic that eliminates bacterial skin infections by inhibiting bacterial protein synthesis, and
• Clotrimazole, an imidazole antifungal that eliminates fungal skin infections by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane.

Doctors commonly prescribe this combination for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses with secondary bacterial and fungal infections. Hospitals, clinics, and pharmacies rely on this formulation for its consistent quality and dependable results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• IP-standard compliant topical triple combination therapy
• Treats inflammatory, pruritic dermatoses with bacterial and fungal infection
• Delivers combined anti-inflammatory, antibacterial, and antifungal action
• Contains Betamethasone 0.025% + Neomycin 0.5% + Clotrimazole 1%
• Maintains a high-purity, stable formulation
• Convenient 15 g tube for topical application
• Suits hospital, clinical, and pharmacy use